New Zealand markets closed

CSPC Pharmaceutical Group Limited (1093.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
6.600+0.080 (+1.23%)
At close: 04:08PM HKT
Currency in HKD

Valuation measures4

Market cap (intra-day) 78.51B
Enterprise value 65.13B
Trailing P/E 12.35
Forward P/E 11.51
PEG ratio (5-yr expected) 2.67
Price/sales (ttm)2.31
Price/book (mrq)2.19
Enterprise value/revenue 2.07
Enterprise value/EBITDA 7.63

Trading information

Stock price history

Beta (5Y monthly) 0.72
52-week change 3-17.29%
S&P500 52-week change 322.36%
52-week high 38.250
52-week low 35.200
50-day moving average 36.187
200-day moving average 36.245

Share statistics

Avg vol (3-month) 338.91M
Avg vol (10-day) 345.3M
Shares outstanding 511.9B
Implied shares outstanding 611.9B
Float 88.26B
% held by insiders 129.79%
% held by institutions 132.01%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.28
Forward annual dividend yield 44.24%
Trailing annual dividend rate 30.25
Trailing annual dividend yield 33.90%
5-year average dividend yield 42.08
Payout ratio 446.38%
Dividend date 3N/A
Ex-dividend date 431 May 2024
Last split factor 28:5
Last split date 316 Oct 2020

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 18.67%
Operating margin (ttm)23.59%

Management effectiveness

Return on assets (ttm)9.96%
Return on equity (ttm)18.22%

Income statement

Revenue (ttm)31.45B
Revenue per share (ttm)2.65
Quarterly revenue growth (yoy)1.90%
Gross profit (ttm)N/A
EBITDA 7.93B
Net income avi to common (ttm)5.87B
Diluted EPS (ttm)0.530
Quarterly earnings growth (yoy)-15.10%

Balance sheet

Total cash (mrq)13.76B
Total cash per share (mrq)1.16
Total debt (mrq)706.9M
Total debt/equity (mrq)2.02%
Current ratio (mrq)2.63
Book value per share (mrq)2.80

Cash flow statement

Operating cash flow (ttm)4.18B
Levered free cash flow (ttm)1.16B